Invex Therapeutics Ltd. (AU:IXC)
ASX:IXC
Australian Market
Holding AU:IXC?
Track your performance easily

Invex Therapeutics Ltd. (IXC) Income Statement

3 Followers

Invex Therapeutics Ltd. Income Statement

Last quarter (Q4 2022), Invex Therapeutics Ltd.'s total revenue was AU$―, a decrease of ― from previous quarter. In Q4, Invex Therapeutics Ltd.'s net income was AU$―. See Invex Therapeutics Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 22Jun 21Jun 20
Total Revenue
----
Cost of Revenue
----
Gross Profit
----
Operating Expense
-AU$ 4.24MAU$ 2.44MAU$ 3.41M
Operating Income
-AU$ -4.24MAU$ -2.44MAU$ -3.41M
Net Non Operating Interest Income Expense
-AU$ 79.88KAU$ 158.78KAU$ 165.70K
Other Income Expense
-AU$ 208.66K-AU$ -117.95K
Pretax Income
-AU$ -3.95MAU$ -2.28MAU$ -3.36M
Tax Provision
-AU$ 0.00AU$ 0.00AU$ 0.00
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
-AU$ -3.95MAU$ -2.28MAU$ -3.36M
Basic EPS
-AU$ -0.05AU$ -0.03AU$ -0.06
Diluted EPS
-AU$ -0.05AU$ -0.03AU$ -0.06
Basic Average Shares
-AU$ 75.15MAU$ 75.15MAU$ 56.17M
Diluted Average Shares
-AU$ 75.15MAU$ 75.15MAU$ 56.17M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
----
Net Income From Continuing And Discontinued Operation
-AU$ -3.95MAU$ -2.28MAU$ -3.36M
Normalized Income
-AU$ -3.95MAU$ -2.28MAU$ -3.24M
Interest Expense
----
EBIT
-AU$ -4.24MAU$ -2.44MAU$ -3.41M
EBITDA
-AU$ -4.24MAU$ -2.44MAU$ -3.41M
Currency in AUD

Invex Therapeutics Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis